Nuclear and Radiological Countermeasure Advisory Board

Steven Bice served for 35 years with the Centers for Disease Control and Prevention (CDC).  Mr. Bice served as the head of the Strategic National Stockpile (SNS) from its inception in 1999, until his retirement in 2005.  Under his leadership, the SNS shipped more than 50 tons of emergency medical supplies to New York City within 7 hours of the terrorist attacks of September 11th.  From 2001 until he retired, Mr. Bice led the rapid expansion of this program and other efforts that make up the backbone of U.S. defenses against biological attack.  Mr. Bice also personally oversaw the establishment of the Emergency Operations Center for CDC.  As Director of Emergency Operations, Mr. Bice managed continuous deployments of critical medical staff throughout the world to address medical emergencies including SARS, avian flu, and the tsunami in Southeast Asia. In 2005, Mr. Bice received the Services to America Medal for Homeland Security for his work at CDC.  

Martin Hauer-Jensen, M.D., Ph.D. is a Professor of Surgery and Pathology at the University of Arkansas Cancer Research Center. Dr. Jensen leads a team that investigates the basic mechanisms of radiation injury and developing strategies to prevent, reduce, or treat radiation injury.   These studies provide insight into the basic pathogenesis of normal tissue radiation toxicity and help reduce the risk of radiation-induced side effects.  Dr. Hauer-Jensen is a Project Leader and member of the Steering Committee for the Radiation Countermeasures Center of Research Excellence (RadCCORE) at Duke University and a reviewer and advisor for the Radiation Event Medical Management (REMM) group at the U.S. Dept. of Health and Human Services. He has served as member and chair of the radiation study section of the NIH.

Hans Klingemann, M.D., Ph.D. is a Professor of Medicine and the Director of the Bone Marrow & Hematopoietic Stem Cell Transplant Program at Tufts University School of Medicine.  Prior to his role at Tufts University, Dr. Klingemann was the Chief of the Bone Marrow Transplant and Cell Therapy section at Rush University Medical Center in Chicago where he built a nationally recognized program in hematopoietic cell transplantation.  Dr. Klingemann is actively performing clinical research evaluating the therapeutic potential of mesenchymal stem cells.  Dr. Klingemann is an international authority in the field of stem cell transplantation whose publications include over 150 original manuscripts, 15 book chapters, 9 books, and many editorials and reviews.

Thomas J. MacVittie, Ph.D. is a Professor in the Departments of Radiation Oncology and Pathology at the University of Maryland, Baltimore, and has more than 30 years of experience as a radiobiologist.  Dr. MacVittie is recognized internationally as an expert in radiation-induced effects on the hematopoietic and gastrointestinal syndrome system.  He has published 135 peer-reviewed manuscripts and 42 chapters in books or proceedings.  Dr. MacVittie is a member of the NIAID/FDA Medical Countermeasures Working Group (WG) as well as the CDC Strategic National Stockpile Radiation WG.  He has served as an advisor to the WHO Collaborating Centers in Radiation Emergency Medical Preparedness and Assistance and as a member of NATO Radiation Research Study Groups. He is currently a member of the Editorial Board of the journal Stem Cells and serves as an Ad Hoc reviewer for numerous journals and NIH/NIAID and DoD grants and contracts.

Major General John S. Parker, U.S. Army (Ret.) is currently Senior Vice President, Corporate Development, Enterprise and Infrastructure Solutions Group, serving as Chief Scientist supporting SAIC’s efforts in the national homeland defense areas of chemical and biological defense, public health, and biosurveillance and biological threat reduction.  Among his many appointments in 37 years of distinguished military service, General Parker was Commanding General, U.S. Army Medical Research and Materiel Command; Special Assistant Secretary of Defense for Medical, Chemical and Biological Defense; and as Commanding General of Medical Contracting Activity at Fort Detrick, he was the Army’s Principal Proponent for Medical Advanced Technology.  General Parker is a major consultant in the broad area of defense against Weapons of Mass Destruction (WMD), and is viewed by The White House, The Congress, and Agencies of the Executive Branch and numerous academic institutions as a credible expert in the field.